Vaccination of endangered wildlife as a conservation tool: Hindsights and new horizons in the pandemic era

Abstract

Vaccines are an established conservation tool that can reduce the threat of infectious disease in endangered wildlife populations. Vaccines exist for many infectious pathogens, and at a time of rapid technological advances in vaccinology, developing vaccines and vaccination programs for free-living endangered wildlife could help efforts to prevent extinctions from disease threats. Vaccination efforts could focus on protecting members of the target species or could be directed at reservoir populations to prevent pathogen spillover. Vaccination strategies need to be substantiated by research on safety and effectiveness, include risk and feasibility assessments, account for differences in host biology and disease epidemiology, and align with relevant regulatory frameworks. Engagement with stakeholders and the public is important to ensure the success of endangered species vaccination programs. Challenges such as funding, regulation, and societal acceptance are barriers to progress in vaccination programs for some species and geographic regions. We recommend the development of scientifically based international guidelines and a transdisciplinary forum with a specific emphasis on endangered wildlife vaccination. New technologies could be used collaboratively to prevent transmission of diseases for which vaccines are not currently available. Careful approaches and enhanced collaborations could help ensure the successful development of wildlife vaccination programs and promote resilience of endangered wildlife populations to increasing anthropogenic and environmental stressors on biodiversity.